Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Founded in 1999, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom strives to simplify and improve diabetes management around the world.
CGM systems are medical devices that can show wearers’ glucose levels (including the rate of change and direction) throughout the day and night. Studies have demonstrated that Dexcom CGM use can support a reduction in A1C levels1,2 and hypoglycemia,1,3,4 and increase time in target glycemic range.1
The alarm and alerts provided by Dexcom CGM Systems can help wearers reduce or prevent highs and lows, and data insights support users’ understanding of the impact of health choices on glucose levels. Dexcom CGM reduces some of the guesswork that comes with making diabetes treatment decisions, offering our users’ greater peace of mind.
1 Beck RW et al. JAMA 2017;317:371-8. 2 Lind M et al. JAMA 2017;317:379-87. 3 Heinemann L et al. Lancet 2018;391:1367-77. 4 Olafsdottir AF et al. Diabetes Technol Ther 2018;20:274-84.